A. Hachisuka et al., CHARACTERIZATION AND TISSUE DISTRIBUTION OF OPIOID-BINDING CELL-ADHESION MOLECULE (OBCAM) USING MONOCLONAL-ANTIBODIES, Neurochemistry international, 28(4), 1996, pp. 373-379
Monoclonal antibodies to opioid-binding cell adhesion molecule (OBCAM)
were produced against a synthetic OBCAM peptide. Immunoblotting analy
sis revealed that the antibodies reacted with 58 and/or 51 kDa protein
s in P2 membranes from bovine, rat, mouse, guinea pig and rabbit brain
s. In bovine brain, the 58 and 51 kDa proteins were present in the str
iatum and cerebral cortex at high levels, but not in the pituitary. OB
CAM was also detected in the cerebellum mainly in the 51 kDa form. In
other tissues, the proteins were found in the spleen at very low level
s, but not at all in the liver or kidney of the rat. OBCAM was effecti
vely solubilized from bovine P2 membranes by bacterial phosphatidylino
sitol specific-phospholipase C (PI-PLC), indicating that OBCAM is a gl
ycosylphosphatidylinositol (GPI)-anchored protein. PI-PLC treatment, h
owever, had little effect on the opioid binding activity of the residu
al P2 membranes. The molecular weight of the proteins (58 and 51 kDa)
was reduced to 36 kDa following treatment with N-glycanase but not fur
ther reduced after subsequent treatment with neuraminidase and O-glyca
nase, suggesting that OBCAM has N-glycosylated carbohydrate chains and
that its two isoforms are different, at least, in the degree of N-gly
cosylation. Taken together, these results suggest that OBCAM consists
of 58/51 kDa GPI-anchored glycoproteins which are highly N-glycosylate
d and are expressed mainly in the nervous system. (C) 1996 Elsevier Sc
ience Ltd.